Research

Learn more about our psoriasis research

 

Psoriasis research

We have a comprehensive research programme led by the Skin Therapy Research Unit (part of the genetics and molecular medicine division at King’s College London). Our work includes clinical trials and research studies assessing new treatments in psoriasis.

How can I get involved in research?

Email us at dermatologytrials@gstt.nhs.uk.

You may be interested in taking part in one of our research projects or clinical trials. You can find details below of the projects we are currently recruiting to.

  • Research studies

    APRICOT – a clinical trial for patients with palmo-plantar pustulosis
    (Anakinra for Pustular psoriasis, Response In a Controlled Trial)

    APRICOT is a clinical trial aiming to find out if anakinra (Kineret) may be an effective treatment for patients with palmo-plantar pustulosis. The trial includes an 8 week treatment period and a couple of follow up visits. We are actively looking for participants at Guy’s Hospital and our other centres around the UK (Manchester, Newcastle, Cardiff, Dundee, Bradford, Liverpool).

    If you are interested please get in touch via our website: www.apricot-trial.com or dermatologytrials@gstt.nhs.uk

    PLUM – a research study for patients with pustular psoriasis
    (Pustular psoriasis, eLucidating Underlying Mechanisms)

    PLUM is a research study aiming to find out what causes pustular psoriasis. Participants will be asked to provide blood samples and clinical information on their history with the disease. We are looking for patients with all forms of pustular psoriasis.

    BSTOP – a research study for patients with psoriasis
    (Biomarkers of Systemic Treatment Outcomes in Psoriasis)

    BSTOP is a research study to find out the causes of psoriasis and patient’s responses to treatment. Participants are asked to provide blood samples and will be followed at a number of visits to collect information as they progress with treatment.

    PSORT-D – a research study for patients with psoriasis
    (Psoriasis Stratification to Optimise Relevant Therapy – Discovery)

    PSORT-D is a research study for patients with psoriasis and particularly those who are just starting a new treatment. Participants provide samples at intervals with the aim of finding out about responses to standard psoriasis treatment over time.

    BADBIR – a register for patients with psoriasis
    (British Association of Dermatology Biologic Interventions Register)

    BADBIR is a national register of patients with psoriasis. Participants provide information at their clinic visits relating to disease and treatment history, complete health questionnaires, and are followed over up to 5 years.

  • Clinical trials

    We also have a number of other clinical trials going on in the department. We often work with drug companies to test new treatments for psoriasis to make sure they are safe and effective before being licensed in the NHS. Your doctor will talk to you about the current trials if they think you might be suitable.

  • Patient and public involvement meetings

    We have an active patient and public involvement (PPI) group which meets to discuss the latest developments in psoriasis clinic and research. If you would like to join us, please email dermatologytrials@gstt.nhs.uk.

    The last meeting was held on Tuesday 31 October 2017.

  • Team

    Prof Catherine Smith

    Prof Jonathan Barker

    Dr Andrew Pink

    Aisling Clery, research nurse

    John Gregory, research nurse

    Louise Griffiths, research nurse

    Emmanuel Toni, research nurse

    Any member of the team can be contacted on dermatologytrials@gstt.nhs.uk or 07717 697 435.

 

 

 

 

Contact

There are a number of studies currently open actively looking for recruits.

For more information about our trials or if you are interested in taking part, please email dermatologytrials@
gstt.nhs.uk

 

I would definitely recommend taking part in research… new treatments need patient involvement and I wanted to help others in the future

Jane Johnston a participant in one of our clinical trials